These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16538614)

  • 1. PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas.
    van Nederveen FH; Perren A; Dannenberg H; Petri BJ; Dinjens WN; Komminoth P; de Krijger RR
    J Pathol; 2006 Jun; 209(2):274-80. PubMed ID: 16538614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional Pten knock-out mice: a model for metastatic phaeochromocytoma.
    Korpershoek E; Loonen AJ; Corvers S; van Nederveen FH; Jonkers J; Ma X; Ziel-van der Made A; Korsten H; Trapman J; Dinjens WN; de Krijger RR
    J Pathol; 2009 Mar; 217(4):597-604. PubMed ID: 19142977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trp53 inactivation leads to earlier phaeochromocytoma formation in pten knockout mice.
    Korpershoek E; Kloosterhof NK; Ziel-van der Made A; Korsten H; Oudijk L; Trapman J; Dinjens WN; de Krijger RR
    Endocr Relat Cancer; 2012 Dec; 19(6):731-40. PubMed ID: 22930559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients.
    Zainuddin N; Jaafar H; Isa MN; Abdullah JM
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):748-56. PubMed ID: 16124450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutation of PTEN in bladder carcinoma.
    Aveyard JS; Skilleter A; Habuchi T; Knowles MA
    Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
    Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
    Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas.
    Aguiar RC; Dahia PL; Sill H; Toledo SP; Goldman JM; Cross NC
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):93-6. PubMed ID: 8796144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
    Korpershoek E; Stobbe CK; van Nederveen FH; de Krijger RR; Dinjens WN
    Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of PTEN mutation in non-familial pheochromocytoma.
    Puc J; Placha G; Wocial B; Podsypanina K; Parsons R; Gaciong Z
    Ann N Y Acad Sci; 2006 Aug; 1073():317-31. PubMed ID: 17102102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.